Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,185 | 245 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $659.60 | 35 | $0 (2024) |
| GlaxoSmithKline, LLC. | $532.22 | 43 | $0 (2024) |
| Novo Nordisk Inc | $496.30 | 28 | $0 (2024) |
| PFIZER INC. | $439.21 | 24 | $0 (2024) |
| Amgen Inc. | $255.91 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $227.15 | 14 | $0 (2024) |
| Lilly USA, LLC | $223.26 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $149.05 | 9 | $0 (2023) |
| Astellas Pharma US Inc | $143.85 | 7 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $141.17 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $882.35 | 49 | GlaxoSmithKline, LLC. ($177.36) |
| 2023 | $1,389 | 84 | ABBVIE INC. ($224.08) |
| 2022 | $1,018 | 59 | ABBVIE INC. ($206.09) |
| 2021 | $895.26 | 53 | AbbVie Inc. ($200.01) |
All Payment Transactions
245 individual payment records from CMS Open Payments — Page 3 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Diabetes | ||||||
| 12/08/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Gastroenterology | ||||||
| 10/31/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: RESPIRATORY | ||||||
| 10/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Diabetes | ||||||
| 10/23/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Inflammation | ||||||
| 10/20/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: PAIN | ||||||
| 10/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Diabetes | ||||||
| 10/09/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: PSYCHIATRY | ||||||
| 10/05/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Diabetes | ||||||
| 10/03/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: UROLOGY | ||||||
| 09/28/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: PAIN | ||||||
| 09/25/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: INSOMNIA | ||||||
| 09/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/24/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 2,838 | 3,940 | $273,607 | $95,808 |
| 2022 | 44 | 2,829 | 3,918 | $288,610 | $101,739 |
| 2021 | 42 | 3,371 | 4,557 | $318,093 | $112,450 |
| 2020 | 45 | 3,326 | 4,299 | $266,539 | $96,225 |
All Medicare Procedures & Services
174 procedure records from CMS Medicare Utilization — Page 7 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 15 | 16 | $2,521 | $747.43 | 29.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 43 | 43 | $1,527 | $711.85 | 46.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 66 | 69 | $2,481 | $710.07 | 28.6% |
| 82728 | Ferritin (blood protein) level | Office | 2020 | 41 | 50 | $1,369 | $677.99 | 49.5% |
| 87086 | Bacterial colony count, urine | Office | 2020 | 50 | 67 | $1,085 | $538.29 | 49.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 18 | 18 | $1,721 | $537.66 | 31.2% |
| 83550 | Iron binding capacity | Office | 2020 | 42 | 52 | $910.90 | $452.27 | 49.7% |
| 80048 | Blood test, basic group of blood chemicals | Office | 2020 | 34 | 47 | $800.88 | $395.24 | 49.4% |
| 83540 | Iron level | Office | 2020 | 42 | 52 | $674.32 | $334.75 | 49.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 22 | 22 | $815.00 | $330.08 | 40.5% |
| 82746 | Folic acid level | Office | 2020 | 22 | 22 | $646.80 | $322.24 | 49.8% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | Office | 2020 | 22 | 31 | $536.30 | $267.47 | 49.9% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2020 | 22 | 31 | $500.96 | $249.84 | 49.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2020 | 38 | 43 | $499.64 | $247.34 | 49.5% |
| 81003 | Automated urinalysis test | Office | 2020 | 88 | 107 | $481.50 | $239.55 | 49.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2020 | 38 | 43 | $447.76 | $221.74 | 49.5% |
| 81001 | Manual urinalysis test with examination using microscope | Office | 2020 | 54 | 72 | $460.68 | $186.84 | 40.6% |
| 84550 | Uric acid level, blood | Office | 2020 | 37 | 41 | $371.64 | $183.88 | 49.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 18 | 20 | $596.34 | $181.45 | 30.4% |
| 83735 | Magnesium level | Office | 2020 | 20 | 23 | $308.20 | $153.71 | 49.9% |
| 83690 | Lipase (fat enzyme) level | Office | 2020 | 16 | 16 | $222.00 | $109.40 | 49.3% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2020 | 19 | 20 | $207.20 | $103.50 | 50.0% |
| 82150 | Amylase (enzyme) level | Office | 2020 | 16 | 16 | $208.80 | $102.90 | 49.3% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation | Office | 2020 | 17 | 17 | $93.00 | $45.75 | 49.2% |
About Stacey Stinger, ARNP
Stacey Stinger, ARNP is a Family healthcare provider based in Port Charlotte, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2014. The National Provider Identifier (NPI) number assigned to this provider is 1619374451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stacey Stinger, ARNP has received a total of $4,185 in payments from pharmaceutical and medical device companies, with $882.35 received in 2024. These payments were reported across 245 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,185).
As a Medicare-enrolled provider, Stinger has provided services to 12,364 Medicare beneficiaries, totaling 16,714 services with total Medicare billing of $406,222. Data is available for 4 years (2020–2023), covering 174 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Port Charlotte, FL
- Active Since 11/21/2014
- Last Updated 04/23/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1619374451
Products in Payments
- TRELEGY ELLIPTA (Drug) $395.97
- VRAYLAR (Drug) $312.00
- NURTEC ODT (Drug) $280.10
- Ozempic (Drug) $260.49
- XARELTO (Drug) $227.15
- Otezla (Drug) $192.92
- UBRELVY (Drug) $164.23
- XIFAXAN (Drug) $141.17
- SHINGRIX (Biological) $136.25
- ELIQUIS (Drug) $126.95
- Rybelsus (Drug) $124.49
- QULIPTA (Drug) $114.21
- Tymlos (Drug) $106.67
- NEXLETOL (Drug) $106.29
- ENTRESTO (Drug) $97.87
- COLOGUARD DNA CAPTURE REAGENTS (Device) $80.50
- EMGALITY (Drug) $75.98
- Veozah (Drug) $73.55
- Myrbetriq (Drug) $70.30
- GLASSIA (Biological) $64.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Port Charlotte
Annmarie Richardson, Arnp, ARNP
Family — Payments: $10,380
Stacy Jean
Family — Payments: $7,814
Monica Gomez, Aprn, APRN
Family — Payments: $4,929
Rose Marie Mccafferty, Arnp, ARNP
Family — Payments: $4,117
Jennifer Caluori, Arnp, ARNP
Family — Payments: $3,907
Natalie Desantis, Aprn, APRN
Family — Payments: $3,298